Literature DB >> 3340164

Basic fibroblast growth factor fused to a signal peptide transforms cells.

S Rogelj1, R A Weinberg, P Fanning, M Klagsbrun.   

Abstract

Basic fibroblast growth factor (bFGF) is a potent growth and angiogenic factor that is found in abundance in tissues such as brain, hypothalamus, kidney and cartilage. Despite this copious production of bFGF, most of these tissues are not undergoing either active growth or angiogenesis, suggesting that bFGF activity must be regulated so as to prevent autostimulation of cell growth. In cultured cells, bFGF is associated mainly with cells and basement membranes and is not released into the medium. Prevention of release could be a mechanism for regulation of bFGF activity and may be a consequence of the apparent absence of a secretory-signal sequence in the bFGF protein. Here we investigate whether this regulation can be overridden through the forced secretion of bFGF. Such secretion might provide the bFGF access to its receptor and in turn lead to autocrine transformation of the cell. We report that bFGF, as specified by a recombinant plasmid, is itself unable to induce such transformation, but acquires this ability after fusion with a secretory-signal sequence. The resulting transformants undergo unusual morphological alteration and display tumorigenicity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3340164     DOI: 10.1038/331173a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  70 in total

1.  Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique.

Authors:  G F Greene; Y Kitadai; C A Pettaway; A C von Eschenbach; C D Bucana; I J Fidler
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 2.  Seeing strangers or announcing "danger": galectin-3 in two models of innate immunity.

Authors:  Sachiko Sato; Julie Nieminen
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

3.  A novel way to get out of the cell.

Authors:  A Rubartelli; A Bajetto; N Bonifaci; E Di Blas; E Solito; R Sitia
Journal:  Cytotechnology       Date:  1993-01       Impact factor: 2.058

4.  Assignment by in situ hybridization of a fibroblast growth factor receptor gene to human chromosome band 10q26.

Authors:  M G Mattei; A Moreau; M C Gesnel; E Houssaint; R Breathnach
Journal:  Hum Genet       Date:  1991-05       Impact factor: 4.132

5.  Acidic and basic fibroblast growth factors augment growth of fetal brain tissue grafts.

Authors:  M M Giacobini; B J Hoffer; G Zerbe; L Olson
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

Review 6.  Modes of FGF release in vivo and in vitro.

Authors:  P A D'Amore
Journal:  Cancer Metastasis Rev       Date:  1990-11       Impact factor: 9.264

7.  Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma.

Authors:  Y Kitadai; L M Ellis; S L Tucker; G F Greene; C D Bucana; K R Cleary; Y Takahashi; E Tahara; I J Fidler
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

8.  The basic residues of placenta growth factor type 2 retrieve sequestered angiogenic factors into a soluble form: implications for tumor angiogenesis.

Authors:  G Barillari; L Albonici; O Franzese; A Modesti; F Liberati; P Barillari; B Ensoli; V Manzari; G Santeusanio
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

9.  Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth.

Authors:  F Cozzolino; M Torcia; M Lucibello; L Morbidelli; M Ziche; J Platt; S Fabiani; J Brett; D Stern
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

10.  Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas.

Authors:  R K Singh; M Gutman; C D Bucana; R Sanchez; N Llansa; I J Fidler
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.